Latest The Institute of Cancer Research Stories
A network of signals active in almost all types of cancer sends the protein factories in our cells into overdrive, and may help fuel a tumor's uncontrolled growth.
Scientists have identified the first genetic variant specifically associated with the risk of a difficult-to-diagnose cancer sub-type accounting for around 10-15 per cent of all breast cancer cases.
Early humans may have evolved black skin to protect against a very high risk of dying from ultraviolet light (UV)-induced skin cancer, a new analysis concludes.
Scientists have described a new family of proteins that appear to play a key role in cancer and might be targets for future cancer drugs.
Collagen, the stuff of ligaments and skin, and the most abundant protein in the human body, has an extraordinary role in triggering chemical signals that help protect the body from cancer, a new study reveals.
A gene that helps control the aging process by acting as a cell's internal clock has been linked to cancer by a major new study.
A new drug combination could offer hope to children with neuroblastoma – one of the deadliest forms of childhood cancer – by boosting the effectiveness of a promising new gene-targeted treatment.
LOS ALTOS, Calif., Dec. 16 /PRNewswire/ -- IronKey, maker of the world's most secure flash drives, today announced that it is providing The Royal Marsden Hospital with its secure, managed USB flash drives to protect data in transit.
Cancer drug developer Antisoma (LSE: ASM; USOTC: ATSMY), The Institute of Cancer Research (The Institute) and Cancer Research Technology (CRT) today announced a collaboration and licensing agreement under which Antisoma has acquired rights to develop and commercialise novel anti-cancer compounds called PPM1D (protein phosphatase magnesium-dependent 1 d) inhibitors.
- Withering but not falling off, as a blossom that persists on a twig after flowering.